Inactive Instrument

News Spectrum Pharmaceuticals, Inc.

Stocks

SPPI

US84763A1088

Biotechnology & Medical Research

All News

02/08/23	Spectrum Pharmaceuticals, Inc.(NasdaqCM:SPPI) dropped from S&P Global BMI Index	CI
02/08/23	Spectrum Pharmaceuticals, Inc.(NasdaqCM:SPPI) dropped from S&P TMI Index	CI
01/08/23	Spectrum Pharmaceuticals, Inc. Announces Cessation of Directors	CI
01/08/23	Spectrum Pharmaceuticals, Inc.(NasdaqCM:SPPI) dropped from NASDAQ Composite Index	CI
01/08/23	Assertio Holdings, Inc. Closes Spectrum Pharmaceuticals Transaction	AQ
28/07/23	Assertio Holdings, Inc. Announces Favorable Vote on Proposed Acquisition of Spectrum Pharmaceuticals	AQ
20/07/23	Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “FOR” Proposed Transaction with Assertio Holdings, Inc.	BU
30/06/23	SPECTRUM PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Spectrum Pharmaceuticals, Inc. - SPPI	BU
17/05/23	Spectrum Pharmaceuticals Regains Nasdaq Compliance	MT
17/05/23	Spectrum Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement	BU
15/05/23	Jefferies Downgrades Spectrum Pharmaceuticals to Hold From Buy, Cuts Price Target to $1.50 From $3.50	MT
09/05/23	Spectrum Pharma: Q1 Earnings Snapshot	AQ
09/05/23	Spectrum Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
09/05/23	Earnings Flash (SPPI) SPECTRUM PHARMACEUTICALS Reports Q1 Revenue $15.6M	MT
09/05/23	Spectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update	BU
08/05/23	B. Riley Lifts Spectrum Pharmaceuticals' Price Target to $1.14 From $1 on Heels of Announced Sale to Assertio Holdings, Keeps Neutral Rating	MT
02/05/23	SPECTRUM PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)	AQ
26/04/23	JMP Securities Downgrades Spectrum Pharmaceuticals to Market Perform From Market Outperform	MT
26/04/23	HC Wainwright Downgrades Spectrum Pharmaceuticals to Neutral From Buy	MT
26/04/23	JMP Securities Downgrades Spectrum Pharmaceuticals to Market Perform From Outperform	MT
26/04/23	SPECTRUM PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Spectrum Pharmaceuticals, Inc. - SPPI	BU
26/04/23	SPECTRUM PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
05/04/23	SPECTRUM PHARMACEUTICALS INC : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
04/04/23	Spectrum Pharmaceuticals : Current Corporate Presentation	PU
04/04/23	SPECTRUM PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)	AQ